Enerzair Breezhaler inha

Indacaterolum / Mometasoni-17 furoas — caps inh 150/50/160mcg

Novartis Pharma Schweiz AG

Swissmedic67596
Dossier21104
Remboursement
QP 10%
Modifications (16)